Table 3 Univariate Cox Proportional Hazard models of development of HTN during 9-year follow-up
Variables | HR(95%CI) | P value |
|---|---|---|
Gender (male) | 1.61(1.46–1.78) | < 0.001 |
Age (years) | 1.03(1.03–1.04) | < 0.001 |
BMI (kg/m2) | 1.16(1.15–1.18) | < 0.001 |
WC (cm) | 1.06(1.05–1.06) | < 0.001 |
BUN (mmol/L) | 1.11(1.07–1.15) | < 0.001 |
Cr (μmol/L) | 1.00(1.00–1.01) | < 0.001 |
FPG (mmol/L) | 1.26(1.21–1.30) | < 0.001 |
UA (μmol/L) | 1.00(1.00–1.00) | < 0.001 |
AST (U/L) | 1.01(1.00–1.01) | < 0.001 |
ALT (U/L) | 1.00(1.00–1.00) | < 0.001 |
y-GGT (U/L) | 1.00(1.00–1.01) | < 0.001 |
TC (mmol/L) | 1.28(1.22–1.34) | < 0.001 |
TG (mmol/L) | 1.29(1.25–1.33) | < 0.001 |
HDL-C (mmol/L) | 0.86(0.77–0.97) | 0.010 |
LDL-C (mmol/L) | 1.31(1.24–1.38) | < 0.001 |
Apo-A1 (g/L) | 1.02(0.86–1.21) | 0.812 |
Apo-B (g/L) | 3.47(2.95–4.09) | < 0.001 |
eGFR (mL/(min·1.73 m2)) | 1.00(0.99–1.00) | < 0.001 |
FLI categories | < 0.001 | |
< 30 | 1.00(reference) | |
30–59 | 2.17(1.97–2.40) | |
≥ 60 | 3.00(2.61–3.46) |